Clinical Trial Update: Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Lumacaftor in Combination With Ivacaftor [Phase 3]

View source ↗

Summary

A Phase 3 rollover study evaluating long-term safety and efficacy of lumacaftor in combination with ivacaftor for cystic fibrosis has completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Lumacaftor/Ivacaftor

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Cystic Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2019-10-29